Merck

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Merck 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MRK

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. 

CEO
Robert M. Davis
CEORobert M. Davis
Employees
75,000
Employees75,000
Headquarters
Rahway, New Jersey
HeadquartersRahway, New Jersey
Founded
1891
Founded1891
Employees
75,000
Employees75,000

MRK Key Statistics

Market cap
252.57B
Market cap252.57B
Price-Earnings ratio
13.10
Price-Earnings ratio13.10
Dividend yield
3.27%
Dividend yield3.27%
Average volume
13.86M
Average volume13.86M
High today
$100.66
High today$100.66
Low today
$98.32
Low today$98.32
Open price
$98.96
Open price$98.96
Volume
11.81M
Volume11.81M
52 Week high
$105.84
52 Week high$105.84
52 Week low
$73.31
52 Week low$73.31

Stock Snapshot

The current Merck(MRK) stock price is $100.01, with a market capitalization of 252.57B. The stock trades at a price-to-earnings (P/E) ratio of 13.10 and offers a dividend yield of 3.3%.

During the trading session on 2025-12-13, Merck(MRK) shares reached a daily high of $100.66 and a low of $98.32. At a current price of $100.01, the stock is +1.7% higher than the low and still -0.6% under the high.

Trading volume for Merck(MRK) stock has reached 11.81M, versus its average volume of 13.86M.

Over the past 52 weeks, Merck(MRK) stock has traded between a high of $105.84 and a low of $73.31.

Over the past 52 weeks, Merck(MRK) stock has traded between a high of $105.84 and a low of $73.31.

MRK News

TipRanks 20h
Mixed options sentiment in Merck with shares up 0.71%

Mixed options sentiment in Merck (MRK), with shares up 70c, or 0.71%, near $99.72. Options volume roughly in line with average with 46k contracts traded and cal...

Nasdaq 22h
Here Are 2 Affordable Healthcare Stocks to Buy Heading Into 2026

Key Points One of these pharmaceutical leaders overcame a major obstacle and has a strong outlook. The other is actively pushing greater innovation to get aro...

Here Are 2 Affordable Healthcare Stocks to Buy Heading Into 2026
TipRanks 1d
Merck announces CHMP recommendation for expanded Winrevair indication

Merck (MRK) announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use recommended the approval of an expanded indication for...

Analyst ratings

52%

of 27 ratings
Buy
51.9%
Hold
48.1%
Sell
0%

More MRK News

Nasdaq 1d
The Smartest Dividend Stocks to Buy With $5,000 Right Now

When a company earns a profit, it can pay a portion to shareholders as dividends. That's a nice reward for shareholders, providing regular income. However, it's...

The Smartest Dividend Stocks to Buy With $5,000 Right Now
Nasdaq 2d
Ex-Dividend Reminder: Gilead Sciences, Merck and Horace Mann Educators

Looking at the universe of stocks we cover at Dividend Channel, on 12/15/25, Gilead Sciences Inc (Symbol: GILD), Merck & Co Inc (Symbol: MRK), and Horace Mann E...

Ex-Dividend Reminder: Gilead Sciences, Merck and Horace Mann Educators
Simply Wall St 2d
Is It Smart To Buy Merck & Co., Inc. Before It Goes Ex-Dividend?

It looks like Merck & Co., Inc. ( ) is about to go ex-dividend in the next three days. The ex-dividend date occurs one day before the record date, which is the...

Is It Smart To Buy Merck & Co., Inc. Before It Goes Ex-Dividend?
Nasdaq 4d
Here's 1 Major Catalyst Behind Merck Stock's Recent 3.8% Bump

Key Points Merck spent a small fortune on the acquisition of Acceleron Pharma, and so far, it's paying off. Recent phase 2 data suggests the pharmaceutical gi...

Here's 1 Major Catalyst Behind Merck Stock's Recent 3.8% Bump
Barchart 5d
These 2 High-Yield Dividend Stocks Are Some of the Safest Buys Right Now

The Fed just reminded everyone that the path to lower rates won't be a straight line. In late October, policymakers delivered a second cut this year. The benchm...

Nasdaq 5d
Merck's CAPVAXIVE Added To Publicly Funded Adult Immunization Program In Saskatchewan

(RTTNews) - Merck & Co., Inc. (MRK), known as MSD outside the U.S. and Canada, announced Monday that the province of Saskatchewan has added CAPVAXIVE, a 21-vale...

Merck's CAPVAXIVE Added To Publicly Funded Adult Immunization Program In Saskatchewan
Simply Wall St 6d
Merck: Evaluating Valuation After Dividend Hike, New Drug Approvals and Upbeat Analyst Upgrades

Merck (MRK) has been in the spotlight after a cluster of investor friendly moves, from a higher dividend and fresh drug approvals to upbeat Wall Street commenta...

Merck: Evaluating Valuation After Dividend Hike, New Drug Approvals and Upbeat Analyst Upgrades

People also own

Based on the portfolios of people who own MRK. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.